JCS/T2D JCS/T2D
JCS/T2D JCS/T2D
  • Home
  • About
  • Disclaimer
  • Privacy
  • Search
  • Contact Us
  • A Clearer, More Human View of Glucose Patterns

  • Abbott and Dexcom Settle Global Patent Disputes Over CGM Technologies

  • Dexcom G7 15-Day CGM Wins FDA Clearance

  • Dexcom Stelo: First Over-the-Counter Glucose Biosensor Now Available in the U.S.

  • Dexcom Submits 15-Day G7 CGM to FDA for Approval

  • Eli Lilly's Once-Weekly Insulin Efsitora Alfa Shows Positive Phase 3 Results

  • Mounjaro Shortage: A Challenge for Diabetes and Obesity Patients

  • Ozempic Linked to Reduced Tobacco-Related Healthcare Needs

  • Regulatory Hurdles for Awiqli: Approval in Canada and EU, Concerns in the US

  • Subtle Yet Significant Changes: The 2024 ADA Standards of Care in Diabetes

  • Viewing Type 2 Diabetes as a Vascular Disease

  • You are here:  
  • Home
  • Tags
  • Diabetes Management
 

JCS/T2D

We are advocates. We learn. We share. We inform.
Bringing clarity to type 2 diabetes, obesity care, health research, and the data behind them.

Content is provided for educational and informational purposes and is not medical advice.

About Us
JCS Analytics
Contact Us

Copyright © 2026 JCS/T2D - A Diabetes Journey. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.